Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Inmode Ltd (NQ: INMD )

19.50 +0.48 (+2.50%)
Streaming Delayed Price Updated: 10:19 AM EST, Nov 25, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Inmode Ltd

< Previous 1 2
...
6 7 8 9 10 11 12 13 Next >
Benzinga's Top Ratings Upgrades, Downgrades For October 12, 2022
Upgrades 
Via Benzinga
Recap: InMode Q2 Earnings
  InMode (NASDAQ:INMD) reported its Q2 earnings results on Thursday, July 28, 2022 at 07:00 AM. Here's what investors need to know about the announcement. 
Via Benzinga
InMode (INMD) Stock Rises 18% on Record Revenue Expectations
Although it has been a tough year so far, INMD stock is now exploding to the upside management raises revenue expectations. 
Via InvestorPlace
InMode Shares Jump On Better Than Expected Q2 Interim Earnings
Via Benzinga
InMode Stock Scores Relative Strength Rating Upgrade; Hits Key Threshold
On Tuesday, InMode stock got a positive adjustment to its Relative Strength (RS) Rating, to 86 from 72 a day earlier. 
Via Investor's Business Daily
Jim Cramer: 'I Am No Longer A Huge Crypto Guy'
On CNBC’s "Mad Money Lightning Round," Jim Cramer said Inmode Ltd (NASDAQ: INMD) is good company, but people hate the medical device firms. 
Via Benzinga
Boeing, PriceSmart And 80 Biggest Movers From Yesterday
Gainers Sharps Compliance Corp. (NASDAQ: SMED) shares jumped 196.1% to close at $8.44 on Tuesday after the company it will be acquired by an affiliate of Aurora Capital Partners for $8.75 per share. 
Via Benzinga
Recap: InMode Q1 Earnings
InMode (NASDAQ:INMD) reported its Q1 earnings results on Monday, May 2, 2022 at 07:15 AM. Here's what investors need to know about the announcement. 
Via Benzinga
Why Is Canoo Surging By 80%? 52 Stocks Moving In Tuesday's Mid-Day Session
Gainers 
Via Benzinga
Why InMode Stock Is Surging Today
Shares of medical technology company InMode Ltd (NASDAQ: INMD) are trading higher Tuesday after the company issued second-quarter guidance above analyst estimates. 
Via Benzinga
Canaccord Genuity Maintains Buy Rating for InMode: Here's What You Need To Know
Canaccord Genuity has decided to maintain its Buy rating of InMode (NASDAQ:INMD) and lower its price target from $50.00 to $40.00. Shares of InMode are trading down 2.15% over the last 24 hours, at... 
Via Benzinga
InMode Stock Falls Despite Q4 Earnings Beat Consensus
 InMode Ltd (NASDAQ: INMD) posted  
Via Benzinga
InMode: Q4 Earnings Insights
  InMode (NASDAQ:INMD) reported its Q4 earnings results on Thursday, February 10, 2022 at 07:15 AM. Here's what investors need to know about the announcement. 
Via Benzinga
Earnings Scheduled For February 10, 2022
Companies Reporting Before The Bell • Canada Goose Hldgs (NYSE:GOOS) is projected to report quarterly earnings at $1.46 per share on revenue of $584.49 million. 
Via Benzinga
Quick Take Technical Analysis: InMode, Ltd
InMode, Ltd (NASDAQ:INMD) made one final push to a new all... 
Via Benzinga
Jim Cramer Likes This Stock Over Olaplex
On CNBC’s "Mad Money Lightning Round," Jim Cramer said he prefers Danaher Corporation (NYSE: DHR) over InMode Ltd. (NASDAQ: INMD). 
Via Benzinga
7 Deeply Oversold Stocks to Buy Before They Bounce
Stocks often over sell after panicking investors get rid of shares, which eventually leads to the stock bouncing back dramatically. 
Via InvestorPlace
Earnings Outlook For InMode
InMode (NASDAQ:INMD) is set to give its latest quarterly earnings report on Monday, 2022-05-02. Here's what investors need to know before the announcement. Analysts estimate that InMode will report an... 
Via Benzinga
3 Growth Stocks That Will Beat Cathie Wood’s Ark Innovation ETF This Year
These three companies are growing rapidly. These growth stocks should easily perform better than Cathie Wood's ETFs this year. 
Via InvestorPlace
7 Hot Stocks to Buy for a Cold Market
Investors are scared of inflation and rising interest rates, but these hot stocks have done well for awhile and should continue to do so. 
Via InvestorPlace
Earnings Scheduled For May 2, 2022
Companies Reporting Before The Bell • New Gold (AMEX:NGD) is estimated to report quarterly earnings at $0.03 per share on revenue of $212.42 million. 
Via Benzinga
Jim Cramer Shares His Thoughts On AT&T, GoodRx And More
On CNBC’s "Mad Money Lightning Round," Jim Cramer said he doesn’t hate AT&T Inc. (NYS... 
Via Benzinga
Cramer Gives His Opinion On Novocure, InMode, Virgin Galactic And More
On CNBC’s "Mad Money Lightning Round," Jim Cramer said Atkore (NASDAQ: 
Via Benzinga
Idexx Stock Shows Healthy Gains, Hits 80-Plus RS Rating
The past nearly two years people have bought pets as company while they wait out the pandemic. That's given a boost to Idexx stock. 
Via Investor's Business Daily
BHC Stock: 9 Things to Know as Jim Cramer Buys Bausch Health
The Mad Money host announced a new position in Bausch Health amid the spread of the omicron variant. Here's what you should know. 
Via InvestorPlace
Is It Time To Sell Stock In These 10 Top Performers Of 2021?
This year has been a great year for stocks overall, with the SPDR S&P 500 ETF Trust (NYSE: 
Via Benzinga
Got $3,000? Buy This 1 Healthcare Growth Stock Now
This growth company's products are disruptive and its profits are burgeoning. 
Via The Motley Fool
ServiceNow, Nike Lead 5 Stocks Near Buy Points On Positive Tailwinds
ServiceNow is hovering around a buy zone while Nike is flashing an early entry. 
Via Investor's Business Daily
Better Buy: Intuitive Surgical or InMode?
Both medical device makers are picking up steam with every passing quarter. 
Via The Motley Fool
Can Medical Aesthetics Firm InMode Keep Its Picture-Perfect Growth Streak Alive?
Years of solid growth, despite Covid headwinds, could challenge this aesthetics stock. 
Via Investor's Business Daily
< Previous 1 2
...
6 7 8 9 10 11 12 13 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.